These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366 [TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation for unresectable tumors of the liver. Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476 [TBL] [Abstract][Full Text] [Related]
12. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Berber E; Siperstein A Ann Surg Oncol; 2008 Oct; 15(10):2757-64. PubMed ID: 18618182 [TBL] [Abstract][Full Text] [Related]
17. The utility of PET/CT in the management of patients with colorectal liver metastases undergoing laparascopic radiofrequency thermal ablation. Sahin DA; Agcaoglu O; Chretien C; Siperstein A; Berber E Ann Surg Oncol; 2012 Mar; 19(3):850-5. PubMed ID: 21913009 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms. Berber E; Herceg NL; Casto KJ; Siperstein AE Surg Endosc; 2004 Mar; 18(3):390-6. PubMed ID: 14735342 [TBL] [Abstract][Full Text] [Related]
19. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432 [TBL] [Abstract][Full Text] [Related]
20. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome. Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]